CCA
REUN

Column Capital Advisors’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Column Capital Advisors’s Portfolio REUN Stock Details REUN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-170
Closed -$192 – 832
2023
Q2 		$192 Hold
170
– – ﹤0.01% 795
2023
Q1 		$117 Hold
170
– – ﹤0.01% 812
2022
Q4 		$153 Buy
+170
New +$248 ﹤0.01% 818

Column Capital Advisors's REUN Position: Q3 2023 in Review

Column Capital Advisors sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2023, closing a stake of 170 shares — an estimated $192 sold.

Column Capital Advisors first reported a position in REUN in Q4 2022 and held it in 3 quarters. The position peaked at $192 in Q2 2023. 0 funds tracked by Wall St. Rank hold REUN as of Q3 2023.

  • Column Capital Advisors reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
  • Column Capital Advisors sold 170 Reunion Neuroscience Inc. Common Shares shares in Q3 2023, an estimated $192.
  • Column Capital Advisors first reported a position in Reunion Neuroscience Inc. Common Shares in Q4 2022 and held it in 3 quarters.
  • Column Capital Advisors's Reunion Neuroscience Inc. Common Shares position peaked at $192 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.